349 related articles for article (PubMed ID: 16671104)
1. Genetic risk factors associated with lipid-lowering drug-induced myopathies.
Vladutiu GD; Simmons Z; Isackson PJ; Tarnopolsky M; Peltier WL; Barboi AC; Sripathi N; Wortmann RL; Phillips PS
Muscle Nerve; 2006 Aug; 34(2):153-62. PubMed ID: 16671104
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to statin myopathy.
Vladutiu GD
Curr Opin Rheumatol; 2008 Nov; 20(6):648-55. PubMed ID: 18946323
[TBL] [Abstract][Full Text] [Related]
3. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE; Sowell MO; Stender M; Qizilbash N
Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
[TBL] [Abstract][Full Text] [Related]
4. A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.
Vladutiu GD; Bennett MJ; Smail D; Wong LJ; Taggart RT; Lindsley HB
Mol Genet Metab; 2000 Jun; 70(2):134-41. PubMed ID: 10873395
[TBL] [Abstract][Full Text] [Related]
5. Myotoxicity associated with lipid-lowering drugs.
Baer AN; Wortmann RL
Curr Opin Rheumatol; 2007 Jan; 19(1):67-73. PubMed ID: 17143099
[TBL] [Abstract][Full Text] [Related]
6. Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings.
Mosshammer D; Lorenz G; Meznaric S; Schwarz J; Muche R; Mörike K
Fam Pract; 2009 Apr; 26(2):88-95. PubMed ID: 19233960
[TBL] [Abstract][Full Text] [Related]
7. Statin myopathy as a metabolic muscle disease.
Phillips PS; Haas RH
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):971-8. PubMed ID: 18666847
[TBL] [Abstract][Full Text] [Related]
8. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
Nichols GA; Koro CE
Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
[TBL] [Abstract][Full Text] [Related]
9. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.
Ørngreen MC; Dunø M; Ejstrup R; Christensen E; Schwartz M; Sacchetti M; Vissing J
Ann Neurol; 2005 Jan; 57(1):60-6. PubMed ID: 15622536
[TBL] [Abstract][Full Text] [Related]
10. Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study.
Sailler L; Pereira C; Bagheri A; Uro-Coste E; Roussel B; Adoue D; Fournie B; Laroche M; Zabraniecki L; Cintas P; Arlet P; Lapeyre-Mestre M; Montastruc JL
Ann Rheum Dis; 2008 May; 67(5):614-9. PubMed ID: 17768174
[TBL] [Abstract][Full Text] [Related]
11. Metabolic myopathies: evaluation by graded exercise testing.
Elliot DL; Buist NR; Goldberg L; Kennaway NG; Powell BR; Kuehl KS
Medicine (Baltimore); 1989 May; 68(3):163-72. PubMed ID: 2716515
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations associated with carnitine palmitoyltransferase II deficiency.
Taggart RT; Smail D; Apolito C; Vladutiu GD
Hum Mutat; 1999; 13(3):210-20. PubMed ID: 10090476
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for statin-associated rhabdomyolysis.
Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
[TBL] [Abstract][Full Text] [Related]
14. Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways.
Vockley J; Rinaldo P; Bennett MJ; Matern D; Vladutiu GD
Mol Genet Metab; 2000; 71(1-2):10-8. PubMed ID: 11001791
[TBL] [Abstract][Full Text] [Related]
15. Identification of the infant-type R631C mutation in patients with the benign muscular form of CPT2 deficiency.
Musumeci O; Aguennouz M; Comi GP; Rodolico C; Autunno M; Bordoni A; Baratta S; Taroni F; Vita G; Toscano A
Neuromuscul Disord; 2007 Dec; 17(11-12):960-3. PubMed ID: 17651973
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C
Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.
Bonnefont JP; Bastin J; Laforêt P; Aubey F; Mogenet A; Romano S; Ricquier D; Gobin-Limballe S; Vassault A; Behin A; Eymard B; Bresson JL; Djouadi F
Clin Pharmacol Ther; 2010 Jul; 88(1):101-8. PubMed ID: 20505667
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial alterations in muscle biopsies of patients on statin therapy.
Gambelli S; Dotti MT; Malandrini A; Mondelli M; Stromillo ML; Gaudiano C; Federico A
J Submicrosc Cytol Pathol; 2004 Jan; 36(1):85-9. PubMed ID: 15311678
[TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of statin intolerance.
Oh J; Ban MR; Miskie BA; Pollex RL; Hegele RA
Lipids Health Dis; 2007 Mar; 6():7. PubMed ID: 17376224
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in 45 patients with statin-associated myopathy.
Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
